Medulloblastoma treatment cost in South Korea typically depends on the surgical approach and clinic tier, with a brain MRI costing AUD $39 – AUD $145 and primary procedures like a craniotomy running from AUD $23,847 to AUD $54,919. Total expenses usually run 30–50% lower than in Australia. Patients most frequently travel to Seoul, specifically to districts housing major medical hubs like Gangnam.
Typical Medulloblastoma Treatment Costs in South Korea
Bookimed Expert Insight: Advanced neuro-oncology cases benefit from the digital safety systems at Seoul National University Bundang Hospital. Their BESTcare system actively prevents medical errors during complex brain surgeries. For patients needing multidisciplinary care, Asan Medical Centre is the largest centre in South Korea. It handles over 65,000 operations annually, which means its surgical teams manage rare medulloblastoma complications routinely. JCI-accredited facilities like Severance Hospital offer additional quality assurance for international patients.
| Republic of Korea | Thailand | Turkey | |
| Craniotomy | from AUD $23,847 | from AUD $21,679 | from AUD $8,166 |
| Chemotherapy for breast cancer | from AUD $27,749 | from AUD $4,336 | from AUD $1,734 |
| Stereotaxic radiosurgery | - | from AUD $14,452 | from AUD $6,504 |
| Radiation therapy for colorectal cancer | - | from AUD $7,949 | from AUD $10,117 |
No hidden fees – just official clinic prices. Pay at the clinic for Medulloblastoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Medulloblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Medulloblastoma treatment journey.
Professor Do Hyun Nam is a leading neurosurgeon at Samsung Medical Center, specialising in endoscopic brain tumour removal for paediatric and adult patients.